CASI Pharmaceuticals, Inc.
OTCPKCASI Pharmaceuticals enters its upcoming results with short interest at its highest level since the position doubled in late March — and a track record of falling after every earnings print on record. The most striking feature of the short-interest data is what happened around March 24. Short interest as a percentage of free float jumped from roughly 2.8% to above 4.7% in a…
Snapshot as of 9 May 2026
CASI Pharmaceuticals enters its upcoming results with short interest at its highest level since the position doubled in late March — and a track record of falling after every earnings print on record. The most striking…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CASI.F — free to start on ORTEX.
Sign up for free →Open CASI.F on ORTEX